The strong positive correlation between APM signature-based risk score and classical immune checkpoint molecules including VTCN1, PDCDLG2, LAG3, and CD274 further indicated that APM signature score could predict an immunosuppressive and onco-inflammatory microenvironment that supported tumor growth and progression. The gene discussed is CD274; the disease is neoplasm.